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Background: The elderly undergo cardiac surgery more and more frequently, often present multiple comorbidities,
assume chronic therapies, and present a unique physiology. Aim of our study was to analyze the experience of a
referral cardiac surgery center with all types of cardiac surgery interventions performed in patients ≥80 years old
over a six years’ period.
Methods: A retrospective observational study performed in a university hospital. 260 patients were included in the
study (3.5% of the patients undergoing cardiac surgery in the study period).
Results: Mean age was 82 ± 1.8 years. Eighty-five percent of patients underwent elective surgery, 15% unplanned
surgery and 4.2% redo surgery. Intervention for aortic valve pathology and coronary artery bypass grafting were
performed in 51% and 46% of the patients, respectively. Interventions involving the mitral valve were the 26% of
the total, those on the tricuspid valve were 13% and those on the ascending aortic arch the 9.6%. Postoperative
low output syndrome was identified in 44 patients (17%). Mortality was 3.9% and most of the patients (91%) were
discharged from hospital in good clinical conditions. Hospital mortality was lower in planned vs unplanned surgery:
3.8% vs 14% respectively. Chronic obstructive pulmonary disease (OR 9.106, CI 2.275 – 36.450) was the unique
independent predictor of mortality.
Conclusions: Clinicians should be aware that cardiac surgery can be safely performed at all ages, that risk
stratification is mandatory and that hemodynamic treatment to avoid complications is expected.
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The elderly (i.e. patients aged 80 years or more) repre-
sents an increasing percentage of the patients candidate
to undergo major surgery. These patients are different
from other age groups, as they often present multiple
comorbidities, assume chronic therapies, and present a
unique physiology in terms of respiratory, cardiovascular,
and metabolic systems [1,2].
Cardiac surgery is increasingly performed in old
patients too, with many interventions being performed in
emergent or urgent conditions, and not only as planned
surgery [3]. The impact of surgery altogether (extent of
surgery, use of cardiopulmonary bypass (CPB), prolonged
general anesthesia, hemodynamic instability) and the ad-
mission to the intensive care unit (ICU) following surgery* Correspondence: landoni.giovanni@hsr.it
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unless otherwise stated.may have a detrimental effect on the outcome of old
people as compared to younger patients. Despite these
strong important differences, the most appropriate clinical
management for this subset of patients has never been de-
termined, being left mainly to physicians’ clinical decision.
Furthermore, these patients utilize an increasing
portion of ICU capacities, provoking economic and
ethical concerns: is this a reasonable burden in terms
of patients’ outcome and quality of life? [4].
Mortality rate in cardiac surgery performed in octo-
genarians was reported to be very high few decades
ago, approaching the 24% in 1988 [3], and 15.7% in
1991 [5], but recent medical and technologic innova-
tions may have reduced the mortality risk. Octogenar-
ians surely represents a sicker population at increased
risk, but nevertheless many of them undergo cardiac
surgery safely.ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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national referral cardiac surgery center with all types of
cardiac surgery interventions performed in old patients
(i.e. ≥80 years old), in recent years and to evaluate
outcomes.
Methods
The study was conceived in accordance with the Declar-
ation of Helsinki and its amendments. With approval of
local ethical committee (“OSR Ethical Committee”) and
patients’ written consent we collected data from all pa-
tients aged 80 years old or more who underwent cardiac
surgery at San Raffaele Scientific Institute over a six
years’ period. No specific written consent was obtained
for this retrospective observational study since all patients’
data were anonymized and de-identified prior to analysis.
Patients were admitted to the cardiac surgery ward
before the operation (routine preoperative evaluation
is reported in Additional file 1: Table S5), underwent
cardiac surgery under general anesthesia and were
transferred to the ICU after surgery. All patients
received standard premedication (morphine 0.1 mg/kg s.c.
and scopolamine 0.25 mg i.m. one hour before surgery)
and general anesthesia (induction with an intravenous
bolus of propofol, fentanyl and muscle relaxant, mainten-
ance with fentanyl, muscle relaxants and with halogenates
and/or propofol). All patients received an intraoperative
infusion of tranexamic acid: 1 g in 20 minutes followed by
a 400 mg/h infusion. Moderate hypothermia (32-34°C)
was maintained during CPB and myocardial perfusion
during aortic cross clamping was obtained by antegrade
and/or retrograde cold cardioplegia. Activated clotting
time (ACT) was maintained greater than 480 seconds
for CPB, heparin (starting dose = 3 mg/kg) was reversed
with protamine in a 1 to 1 ratio. The mean arterial target
pression was 60 mmHg during CPB and at least 65 mm
Hg after CPB.
After surgery, patients were transferred to the ICU
under sedation with propofol. Weaning from the ventilator
was started as soon as hemodynamic stability was
confirmed with no major bleeding, normothermia, and
an adequate level of consciousness and pain control
were achieved. Standard intravenous therapy included
intravenous antibiotic prophylaxis with cephazolin for
72 hours, hydration, antiacids and diuretics as well as
inotropes and devices as the hemodynamic conditions
required.
Transfer out of the ICU was considered in the presence
of peripheral oxygen hemoglobin saturation (SpO2) ≥94%
at an inspired fraction of oxygen (FiO2) ≤0.5 by facemask,
adequate cardiac stability with no major arrhythmias, chest
tube drainage <50 ml/h, urine output >0.5 ml/kg/h, no
intravenous inotropic or vasopressor therapy in excess
of dopamine 5 μg/kg/min, and no seizure activity.Criteria for hospital discharge to undergo rehabi-
litation program included hemodynamic and cardiac
rhythm stability, the absence of incision site’s infection,
an afebrile condition, normal bowel movement, inde-
pendent ambulation and feeding.
Demographics and clinical characteristics were col-
lected electronically together with preoperative, intraop-
erative, and postoperative data.
Myocardial infarction was defined as suggested by
the Consensus Conference for the Universal Definition
of Myocardial Infarction [6]. Arterial hypotension
(systolic blood pressure <90 mmHg) with signs of
end-organ hypoperfusion (i.e. decreased urine output,
lactic acidosis) despite adequate fluid replacement,
with impairment of cardiac function and normal or high
peripheral vascular resistance, was defined as postoper-
ative low output syndrome. Complete hemodynamic
monitoring was guaranteed for each patients on the
basis of clinical needs. Cardiogenic shock was defined
according to the IABP Shock Trial [7]. Low cardiac
output syndrome (LCOS) was defined as a decrease in
cardiac output due to transient myocardial dysfunction
and included cardiogenic shock as per the IABP shock
trial definition [7].
Acute kidney injury (AKI) was defined as a 50% or
100% increase in serum creatinine value [8]. Creatinine
clearance was calculated with the Cockroft-Gault equa-
tion [9] and the ACEF score was also calculated [10].
We defined as “redo” a patient who had already under-
gone sternotomy for cardiac surgery once in the past.
“Postoperative atrial fibrillation” was defined as abrupt
de novo onset of atrial fibrillation requiring either
pharmacological or electrical cardioversion after car-
diac surgery and during the ICU stay in a patient with
no preexisting history of atrial fibrillation. Type I
neurologic damage was defined as: death due to stroke
or hypoxic encephalopathy, new nonfatal stroke, or
transient ischemic attack (TIA), or stupor or coma at
the time of discharge. Type II neurologic damage was
defined as: a new deterioration in intellectual function,
confusion, agitation, disorientation, memory deficit,
or a nonmetabolic seizure without evidence of focal
injury.
Data were stored electronically and analyzed by
use of SAS (release 9.2 by SAS Institute Inc. Cary,
NC, USA). Categorical variables are reported as
numbers (percent), whereas continuous variables are
expressed as mean ± standard deviation or as median
(interquartile range) according to the Kolmogorov-
Smirnov test. Fisher test was used to calculate p-values
between 2 groups for categorical variables. Multiple
Logistic regression was used to identify independent
predictors of mortality. A stepwise selection method
was used.
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During the study period, 260 (3.5%) out of 7,357 patients
scheduled to undergo cardiac surgery were aged 80 or
more and were included in the study. Baseline character-
istics of the study population are shown in Table 1.
Mean age was 82 ± 1.8 years, and 50% of patients were
male. Forty-six percent of patients were in the functional
NYHA class II, 42% were in class III, 8.4% in class I, and
4% in class IV. Preoperative ejection fraction (EF) was
53.5 ± 10.8%; 17% of patients presented an EF < 40% and
5.9% an EF < 30%, respectively. ACEF score was 1.7 ±
0.5. Despite nearly normal serum creatinine values
(1.06 ± 0.4 mg/dl), creatinine clearance was impaired
(50 ± 16 ml/h).
Eighty-five percent of patients underwent elective
surgery, with 15% received urgent or emergent surgery
(i.e. unplanned surgery); 1.9% of patients had preopera-
tive mechanical circulatory support with intraaortic
balloon pump counterpulsation. Redo surgery was per-
formed in 4.2% of patients.
Data concerning surgical intervention performed are
shown in Table 2. Intervention for aortic valve pathology
and coronary artery bypass grafting (CABG) were the
most frequent operations, being performed in 51% and
46% of the patients, respectively. Twenty-five patients
underwent urgent or emergent CABG surgery (21%). In-
terventions involving the mitral valve were 26% of the
total, those on the tricuspid valve were 13%, and those
on the ascending aortic arch the 9.6%. Intraoperative
and postoperative data are presented in Table 3.
Ninety-one percent of the interventions were per-
formed under CPB and cardioplegic circulatory arrest.
Mean duration of aortic clamping was 61 ± 22 minutes,
and duration of cardiopulmonary bypass was 80 ± 26 mi-
nutes. A relevant portion of patients (42%) required ino-
tropic support for CPB weaning.
Hospital mortality was 3.9%, compared to the 2.2%
mortality rate observed in the 7,357 patients of all ages
undergone cardiac surgery at the same institution in the
same study period. Overall, mortality was lower in
planned surgery compared to unplanned surgery: 2.7%
vs 11% respectively.
Duration of ICU stay and hospital stay were 2 (1–4)
days and 6 (5–9) days (Table 4). Postoperative bleeding
from chest tubes was 240 (170–350) ml in the first 12
postoperative hours. Forty-two percent of patients re-
ceived transfusions during the perioperative period.
Postoperative low output syndrome was identified in
44 patients (17%), cardiogenic shock in 9 (3.5%) and 36
patients (14%) had treatment with inotropes lasting
more than 48 hours.
Four (1.5%) patients had acute myocardial infarction
in the ICU, with median peak troponin value being 7.3
(4.2 - 13) ng/ml. Twenty-seven percent of patients hadat least one episode of atrial fibrillation requiring
pharmacological or electrical cardioversion.
Duration of mechanical ventilation was 15 (12–20)
hours. Six patients (2.3%) required re-intubation due to
respiratory failure after weaning from mechanical venti-
lation. Seven patients (2.7%) had prolonged mechanical
ventilation and received tracheostomy. Acute renal fail-
ure (Table 3) occurred in 11.2% of patients, and 3.1% re-
quired renal replacement therapy. Type 2 neurologic
damage was more frequent than type 1 damage: 2.7 vs
0.77% respectively. The great majority of patients (91%)
was discharged from hospital in good clinical conditions.
Patients were further compared according to the gen-
der (i.e. male versus female). Although many differences
exist between genders in baseline and perioperative data,
notably, no difference was found in the outcomes. (see
Additional file 1 for more details).
Only one preoperative independent predictor of mor-
tality was identified in the overall study population: pre-
operative chronic obstructive pulmonary disease
(COPD) (OR 9.106, with 95% confidence limits 2.275 –
36.450).
Discussion
This is one of the largest experience reported in lite-
rature by a single center on cardiac surgery performed
in octogenarians, which represent the fastest growing
patients’ group candidate to surgery. Typical patho-
physiological changes are present in this population.
Nonetheless, since individuals vary greatly in the rate
at which their organs decline physiological more than
chronological age should be considered in the evalua-
tions of the patients candidate to undergo cardiac sur-
gery [1]. Impairment of organ function manifests at
different levels. Cardiovascular system is strongly af-
fected: the heart, differently from other organs, does
not atrophy with aging, but may become thicker and
larger. The prevalence of diastolic dysfunction is very
high, and cardiac index may be reduced [2]. Our data
indeed show a preoperative ejection fraction ≤ 40% in
17% of patients and a preoperative ejection fraction ≤
30% in 5.9% of cases, but the presence of diastolic dys-
function might be even higher. Furthermore, a deteri-
oration in kidney function can also be observed and
estimated with calculation of glomerular filtration rate,
even if little changes in creatinine plasmatic value
often occur [3]. In the present study, despite nearly
normal serum creatinine values (1.06 ± 0.4 mg/dl), the
calculation of creatinine clearance (50 ± 16 ml/h) dis-
closed the presence of kidney function impairment.
Respiratory, hepatic, metabolic systems show a decline too,
and neurologic impairment is also commonly observed.
For these reasons only a minority of elderly symptom-
atic patients are referred for surgical treatment because
Table 1 Baseline characteristics
Variable Value
Gender (male), n 130 (50%)
Age, y 82 ± 1.8
Height, cm 166 ± 8.5
Weight, kg 68 ± 12.1
BMI 24.8 ± 3.6
Comorbidity
> COPD, n 58 (22%)
> Preoperative EF,% 53.5 ± 10.8
> Preoperative EF ≤40%, n 41 (17%)
> Preoperative EF ≤30%, n 14 (5.9%)
> Peripheral vasculopathy, n 86 (33%)
> Hypertension, n 146 (56%)
> Type II Diabetes, n 32 (12%)
> Carotid stenosis, n 43 (17%)
> Chronic pulmonary disease, n 39 (15%)
> Angina, n 95 (15%)
> Previous AMI, n 38 (15%)
> Previous TIA or stroke, n 115 (44%)
> Previous vascular surgery, n 16 (6.15%)
> Euroscore standard 8.3 ± 2.3
> Endocarditis 5 (1.9%)
> Chronic renal failure, n 32 (12%)
> Dialysis, n 0 (0%)
Charlson Comorbidity Index 6 ± 1.3
NYHA class
> I, n 15 (8.4%)
> II, n 82 (46%)
> III, n 74 (42%)
> IV, n 7 (4%)
Timing of surgery
> Emergency, n 5 (2%)
> Urgency, n 33 (13%)
> Planned, n 222 (85%)
Redo, n 11 (4.2%)
Preoperative IABP, n 5 (1.9%)
Chronic Therapy
> Antiplatelets, n 97 (37%)
> Diuretics, n 141 (54%)
> Betablockers, n 95 (37%)
> Antibiotics, n 5 (1.9%)
> Ca-channels antagonists, n 55 (21%)
> Nitrates, n 66 (25%)
> ACE- inhibitors, n 151 (58%)
> Oral anticoagulants, n 111 (14%)
Table 1 Baseline characteristics (Continued)
> Heparin, n 35 (13%)
Bilirubine, mg/dl 0.8 ± 0.4
Creatinine, mg/dl 1.06 ± 0.4
Data are expressed as mean ± standard deviation or number (percentage).
BMI – body mass index; COPD – chronic obstructive pulmonary disease;
EF – ejection fraction; AMI – acute myocardial infarction; TIA – transient
ischemic attack; NYHA – New York Heart Association; CPB – cardiopulmonary
bypass; IABP – intraaortic balloon pump.
Scandroglio et al. BMC Anesthesiology 2015, 15:15 Page 4 of 8
http://www.biomedcentral.com/1471-2253/15/15the operative risk is considered too high. Not surprisingly,
this fragile population of patients are at higher risk when
operated, but although the mortality rate is higher that 1-
3% usually observed in elective cardiac surgery in the
overall population, we observed an acceptable 3.9% rate in
this specific subset of high risk patients. Forty-two percent
of patients received transfusions during the perioperative
period confirming that advanced age still represents a high
risk category for transfusion, according to the Update
to the Society of Thoracic Surgeons and the Society of
Cardiovascular Anesthesiologist Blood Conservation
Clinical Practice Guidelines [11].
The long duration of mechanical ventilation that we
recorded (i.e. 15 (12–20) hours) has multifactorial
explanations including the long half-life of fentanyl,
pre-existing pulmonary comorbidities, and periopera-
tive factors and complications such as hemodynamic
instability, sepsis, and pneumonia. Notably, preopera-
tive COPD was the only preoperative independent
mortality predictor in this population and it had an
high prevalence in this elderly population.
Recently some studies addressed the issue of performing
cardiac surgery in the old patients: the data published by
Bridgest [12] on coronary surgery and by Biancari [13] on
mitral valve surgery show a trend towards a reduction in
mortality far from that of the nineties. In that period
80 year old patients undergoing heart surgery were
reported to have a 24% mortality rate in the far 1988
[4] and 15.7% by Freeman and colleagues in 1991 [3].
In the last 2 decades, extraordinary technologic develop-
ments and evolution of knowledge has led to a reduction
in mortality. Such developments include improvements in
surgical technique, CPB technology and circuits, the man-
agement of cardioplegic circulation, transfusions policy,
hemodynamic and coagulation monitoring, post-cardiac sur-
gery care (including mechanical circulatory support and
fluid therapy). Clinicians share the common idea that who is
nowadays candidate to CABG surgery is older and sicker
than in the past (more comorbidities, advanced multidistrec-
tual vasculopathy), but a decreasing mortality rate has been
reported in literature for coronary artery bypass surgery
[5,14]. This is a very important topic as coronary artery
bypass surgery is among the most frequent interven-
tions performed in our population of octogenarians,
Table 4 Outcomes
Variable Frequency/Mean 95% CI
Hospital mortality, n 10 (3.9%) 2.1% - 6.9%
ICU stay, days 4 ± 8 3.07 - 5.2
Hospital stay, days 10 ± 11.2 8.36 - 11.11
Clinical condition at hospital discharge
> Dead, n 10 (3.9%) 2.1% - 6.9%
> Extremely poor, n 2 (0.77%) 0.21% - 2.95%
> Poor, n 11 (4.2%) 2.4% - 7.4%
> Good, n 237 (91%) 87% - 94%
Data are expressed as mean ± standard deviation or number (percentage).
ICU – Intensive Care Unit.
Table 3 Intraoperative and postoperative data
Variable Frequency
CPB, n 236 (91%)
Duration of aortic clamping, min 61 ± 22
Duration of CPB, min 80 ± 26
Bleeding in the first 12 postoperative hours, ml 240 (170–350)
Total postoperative bleeding, ml 360 (220–530)
Creatinine peak, mg/dl 1.2 ± 0.6
Serum creatinine increase ≥50%, n 15 (5.8%)
Serum creatinine increase ≥100%, n 6 (2.3%)
Renal replacement therapy, n 8 (3.1%)
Patients receiving hemoderivates, n 110 (42%)
Red Blood Cell transfusions, n of units per patient 1.3 ± 2.34
Fresh frozen plasma transfusions, n of units per patient 0.4 ± 1.34
Platelets transfusions, n of units per patient 0.3 ± 1.58
Neurologic damage type 1, n 2 (0.77%)
Neurologic damage type 2, n 7 (2.7%)
Postoperative AMI, n 4 (1.5%)
Troponine peak, ng/ml 7.3 (4.2 - 13)
Atrial fibrillation, n 70 (27%)
Duration of mechanical ventilation, hours 15 (12–20)
Severe pulmonary dysfunction, n 5 (1.9%)
Mild pulmonary dysfunction, n 16 (6.2%)
Tracheostomy, n 7 (2.7%)
Need for re-intubation, n 6 (2.3%)
Low cardiac output syndrome, n 44 (17%)
Cardiogenic shock, n 9 (3.5%)
Inotropes for more than 48 hours, n 36 (14%)
Sepsis, n 4 (1.5%)
Mediastinitis, n 0 (0%)
Data are expressed as median (interquartile), mean ± standard deviation or
number (percentage).
CPB – cardiopulmonary bypass; IABP – intraaortic balloon pump; AMI – acute
myocardial infarction; ICU – intensive care unit.
Table 2 Surgical interventions
Variable Value
CABG, n of patients 119 (46%)
> Isolated CABG, n of patients 63 (24%)
> Off pump CABG surgery, n 24 (9.2%)
Mitral valve surgery, n 67 (26%)
> Isolated mitral valve surgery, n 19 (7.3%)
> Mitral valve replacement, n 29 (11%)
> Mitral valve repair, n 38 (15%)
Aortic valve surgery, n 132 (51%)
> Isolated aortic valve surgery, n 71 (27%)
> Aortic valve replacement, n 131 (50%)
> Aortic valve repair, n 1 (0.38%)
Tricuspid valve surgery, n 34 (13%)
> Isolated tricuspid valve surgery, n 1 (0.38%)
> Tricuspid valve replacement, n 1 (0.38%)
> Tricuspid valve repair, n 33 (13%)
Ascending aorta surgery, n 25 (9.6%)
> Isolated ascending aorta surgery, n 2 (0.77%)
Data are expressed as number (percentage).
CABG – coronary artery bypass graft.
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published a very interesting study on a very large number
of patients [12]. They reported data from The Society of
Thoracic Surgeons National Database with 59,576 patients
aged 80 who underwent cardiac surgery from 1997 to
2000. In the CABG group of those aged between 80 and
89 the mortality was 7.1%. Notably, mortality rate in
CABG surgery was 3.4% in our study population, which is
lower than mortality of mitral valve and aortic valve sur-
gery in the same population (6% and 3.8%, respectively).
In their conclusion, Bridgest et al. [12] stressed the
concept that, thank to a careful selection, the old pa-
tients candidate to CABG have a lower risk, similar to
that of younger patients.
We strongly agree that such an approach or patients’
risk stratification may help to identify those patients with
good preoperative status for whom age alone should not
be considered a contraindication to surgery.
There are two main open issues regarding CABG
patients: one is the issue of the most critical old
CABG-patients who reach the operating theater in
unstable hemodynamic condition requiring mechanical
circulatory support (5 patients in our case series had
preoperative IABP, of whom 3 underwent CABG), and
the other one is off-pump versus on-pump CABG
surgery. Theoretically off-pump surgery may present
some advantages compared to on-pump cardiac sur-
gery, as systemic inflammation, myocardial injury, and
cerebral injury may be strongly reduced without CPB
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with precarious homeostasis as the elderly. Minimally
invasive surgery for a single vessel bypass might reduce
even more postoperative complications. Besides, off-pump
surgery was shown to be associated with less postoperative
neurologic complications compared to CPB surgery
[17,18]. Mortality in aortic valve surgery is 3.8%, which
seems low considering the characteristics of these pa-
tients who frequently manifest low output postoperative
syndrome because of the anatomic changes of the heart
secondary to the pathology, not always easy to be managed.
This case series doesn’t take in account the percutaneous
procedure of aortic valve replacement (TAVI). In our center
this program of TAVI was still at the beginning in the
period of the present data collection and reserved to the
more complex patients unsuitable for surgery (i.e. calci-
fied aorta, scarring from previous surgery). However,
data from TAVI registries in many countries are very
promising, and TAVI technique might represent one of
the most important innovation in cardiac surgery of the
last years [19-21].
With regards to mitral valve surgery, a recent system-
atic review about octogenarians reported that mortality
risk is rather high (15%) [13]. However, the data clearly
show that the operative risk has been markedly lower in
the most recent series, as a consequence of the improve-
ments in patient selection, surgical techniques, intraop-
erative management, and postoperative care. Indeed, we
only observed a 6% mortality rate in mitral valve surgery.
Furthermore, institutions with experience in valve repair,
the mitral valve can be effectively reconstructed even in
octogenarians, avoiding prosthesis-related problems.
Using additional procedures only if strictly required may
have positive influence on the patient’s outcome [22-24].
In our institution we proceed according to a strategy
which aims at minimizing the surgery induced trauma
(concomitant surgical procedures are possibly avoided
and expeditious surgical technique of mitral valve repair
is adopted) and at optimizing the treatment of postoper-
ative hemodynamic instability and low output syndrome
given the little tolerance to postoperative complications by
the elderly. The impact of major complication (i.e. acute
renal failure requiring renal replacement therapy, low
output syndrome requiring IABP support and sepsis) on
mortality in octogenarians is enormous: in this series,
patients suffering from at least one of the major compli-
cations above had a mortality rate of 17%. In the elderly
the potential benefits on organ function of new drugs
(eg. levosimendan, fenoldopam) or mechanical circula-
tory support still has to be clarified. Moreover, many
strategies have shown relevant benefits in cardiac sur-
gery, but their role in this subset of patients has never
been investigated: for example the use of postoperative
non invasive ventilation or the use of volatile anestheticsfor maintance of anesthesia were already proven to have
positive effects on outcome and may be confirmed to have
benefits also in octogenarians [25,26].
In our center between 1998 and 2001 the octogenarians
who underwent cardiac surgery were only 1.8% of the
total, but we observed a very low mortality rate (1.8%).
In the light of these data, we expanded our experience
in the following years with less strict contraindications
to surgery, and people aged 80 or more represents now-
adays 3.5% of the patients receiving cardiac surgery, with
a reasonably low mortality (3.85%).
Despite these results, it is still an open issue whether
the benefits, in terms of quality of life expectations after
surgery, outbalance the risk in the elder. Gjeilo and col-
leagues observed an improvement in quality of life in pa-
tients aged 75 years or more from baseline to 6 months
postoperatively, and remained relatively stable 5 years
after cardiac surgery [27]. Khan and collaborators found
that in most octogenarians hospital morbidity is increased,
and hospital stay is longer [28]. On the contrary, Deschka
et al. found that advanced age is correlated with a higher
mortality, but not with prolonged ICU treatment or higher
costs after cardiac surgery [29]. On the opposite, in a
recent study by Meziere et al., age was found to be an
independent risk factor of postoperative mortality and
postoperative complications including cognitive dys-
function, with no impact of the choice of anesthetic
technique on risk [30].
Notably, we were able to identify only 1 mortality risk
predictor at baseline in this population: preoperative
COPD, which is extremely common in the elderly.
Therefore, the stratification of old patients candidate to
undergo cardiac surgery is not trivial.
We acknowledge some limitations of our work. The
study is retrospective and covers a long period of time
during which the perioperative management of cardiac
surgical patients may have been partially changed, both
for young and old persons. We did not mention separ-
ately the postoperative complications due to infection
because of lacking of complete data. We also could not
provide data on diastolic dysfunction, which has a high
prevalence in this population and could be extremely
invalidating. Few definitions used in this paper (eg clin-
ical condition at hospital discharge) are based on local
protocols in the absence of universally accepted inter-
national criteria. We acknowledge also that the trial design
did not include a follow-up. Furthermore, although we
conclude that cardiac surgery may have benefits for the
elderly, a score of the quality of life after surgery was
not available for these patients.
Conclusions
Clinicians should be strongly aware that cardiac surgery
can be safely performed at all ages: meticulous preoperative
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patients and discriminate those patients for whom sur-
gery may be worthwhile (even if mortality predictors
are few and aspecific). Hemodynamic treatment should
be optimized in order to prevent major complications,
as they may dramatically impair the outcome. In par-
ticular, delays and mistakes should be carefully avoided,
as this population of patients is more fragile, and shows
a limited physiologic reserve and resistance to any kind
of stress. Discussion concerning all the therapeutic
options with the patients and with the relatives is
always mandatory.
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